Pfizer Inc (NYSE:PFE) - Share price


Stock Report

Pfizer Inc PFE

Last Price
$39.97

Day Change
0.02|0.05%

As of 05/05/2021
19:59:54 EDT | USD
Minimum 15 Minutes Delay.

Last Close39.95
Day Range38.93 - 41.09
Mkt Cap223.00Bil
52-Wk Range29.95 - 43.08
Yield %3.83
ISINUS7170811035
Volume54,348,362
P/E32.26
P/S5.07
P/CF15.66

Share Price

Financials
201820192020
More ...
Income Statement
Revenue53,647.0051,750.0041,908.00
Operating Income15,045.0013,921.008,760.00
Net Income11,153.0016,273.009,616.00
Basic EPS1.902.921.73
Avg. Diluted Shares Outstanding5,9775,6755,632
Balance Sheet
Current Assets49,926.0032,803.0035,067.00
Non Current Assets109,497.00134,685.00119,163.00
Total Assets159,422.00167,489.00154,229.00
Current Liabilities31,858.0037,304.0025,920.00
Total Liabilities95,664.00104,042.0090,756.00
Total Equity63,407.0063,143.0063,238.00
Cash Flow
Operating Cash Flow15,827.0012,588.0014,403.00
Capital Expenditure-2,196.00-2,594.00-2,791.00
Free Cash Flow13,631.009,994.0011,612.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

Sector

Healthcare

Industry

Drug Manufacturers - General

Stock Style

Large-Value

Fiscal Year Ends

December

Employees

78,500
Key Stats
More ...
Price/Earning TTM23.09
Price/Book3.52
Price/Sales TTM5.37
Rev Growth (3 year avg)-7.26
EPS Growth (3 year avg)-
Operating Margin % TTM20.90
Net Margin % TTM22.95
ROE TTM15.22
Debt/Equity0.56
Dividends
PreviousLatest
More ...
Declared Date11/12/2022/04/21
Ex-Div28/01/2106/05/21
Paid05/03/2104/06/21
Amnt0.390.39
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.